Kinetics of irreversible inhibition of choline transport in synaptosomes by ethylcholine mustard aziridinium
- PMID: 6549400
- DOI: 10.1007/BF01871635
Kinetics of irreversible inhibition of choline transport in synaptosomes by ethylcholine mustard aziridinium
Abstract
Ethylcholine mustard aziridinium (ECMA) inhibits choline transport in synaptosomes at a half-maximal concentration of about 20 microM. The rate of inhibition falls off rapidly after 10 min and the concentration dependency reaches a plateau at about 100 microM. The inhibition is not removed by washing the synaptosomes, and choline and hemicholinium-3 protect the carrier against attack by the mustard. Choline efflux, particularly that stimulated by choline in the medium (transactivation) is also inhibited by the aziridinium compound. Similarly choline influx activated by preloaded internal choline is inhibited by ECMA. The mustard can enter the synaptosomes in an active form but most of the carrier is alkylated when facing the outside. Prior depolarization of the synaptosomes causes an increase in the rate of inhibition by ECMA which is proportionally about the same as the increase in choline influx also caused by depolarization. At low ECMA concentrations the rate of inhibition is that of a first-order reaction with the carrier but at high ECMA concentrations the translocation of the carrier to the outward-facing conformation controls the rate of inhibition. Using a model of choline transport with some simplifying assumptions it is possible to estimate the amount of carrier; cholinergic synaptosomes carry about six times the concentration of carrier found in noncholinergic ones. In noncholinergic synaptosomes the carrier faces predominately out, the reverse in cholinergic ones. The rate constant of carrier translocation is increased by combination with choline some six- to sevenfold to about 3.5 min-1. The rate constant of ECMA attack on the carrier is about 440 M-1 sec-1.
Similar articles
-
Specificity of ethylcholine mustard aziridinium as an irreversible inhibitor of choline transport in cholinergic and noncholinergic tissue.J Neurochem. 1987 Jun;48(6):1673-6. doi: 10.1111/j.1471-4159.1987.tb05722.x. J Neurochem. 1987. PMID: 3572397
-
Reversible and irreversible inhibition of high-affinity choline transport caused by ethylcholine aziridinium ion.J Neurochem. 1987 Aug;49(2):468-74. doi: 10.1111/j.1471-4159.1987.tb02888.x. J Neurochem. 1987. PMID: 3598581
-
Effects of acetylcholine mustard aziridinium ion and its choline analogue on choline transport into synaptosomes.Can J Physiol Pharmacol. 1977 Aug;55(4):769-72. doi: 10.1139/y77-104. Can J Physiol Pharmacol. 1977. PMID: 902152
-
Choline transport specificity in animal cells and tissues.Comp Biochem Physiol C Comp Pharmacol Toxicol. 1989;93(1):1-9. doi: 10.1016/0742-8413(89)90002-9. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1989. PMID: 2567220 Review.
-
The transport of choline.Drug Dev Ind Pharm. 2002 Aug;28(7):749-71. doi: 10.1081/ddc-120005622. Drug Dev Ind Pharm. 2002. PMID: 12236062 Review.
Cited by
-
Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.Neurotox Res. 1999 Sep;1(1):3-25. doi: 10.1007/BF03033336. Neurotox Res. 1999. PMID: 12835111
-
Differences in control of descending inhibition in the proximal and distal regions of rat colon.Br J Pharmacol. 1990 Dec;101(4):1011-5. doi: 10.1111/j.1476-5381.1990.tb14198.x. Br J Pharmacol. 1990. PMID: 2085703 Free PMC article.
-
Morphological assessment of ethyl choline mustard aziridinium-induced neurotoxicity in rat brain reaggregate cultures.Acta Neuropathol. 1993;86(2):154-62. doi: 10.1007/BF00334882. Acta Neuropathol. 1993. PMID: 8213070
-
Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo.Neurochem Res. 1999 Jan;24(1):15-24. doi: 10.1023/a:1020967711189. Neurochem Res. 1999. PMID: 9973232
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous